Tuesday, December 05, 2023 10:54:36 AM
https://www.globenewswire.com/news-release/2023/12/05/2790905/0/en/Leading-Pan-European-Ferry-and-Logistics-Company-P-O-Ferries-Adopts-Fingerprint-Drug-Screening-Solution-for-On-Board-Random-Testing-of-Seafaring-Staff.html
Intelligent Fingerprinting Drug Screening System is expected to reduce P&O Ferries’ overall drug testing costs by 90%
Easy-to-use, hygienic fingerprint sweat test improves the testing experience for P&O Ferries employees from previous urine method
NEW YORK, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that leading pan-European ferry and logistics company, P&O Ferries, is now using the revolutionary portable Intelligent Fingerprinting Drug Screening System to support its drug and alcohol testing policy.
P&O previously used an external drug testing service provider to conduct random urine testing of seafaring staff on board its ferries. The testing process typically required multiple cabins with toilet facilities, HR support, external testers and a series of two-hour testing sessions across multiple voyages to conduct testing. This approach proved expensive and inflexible. Switching to an in-house program using the Intelligent Fingerprinting Drug Screening System is expected to reduce P&O Ferries’ overall drug testing costs by 90%.
“When we first saw fingerprint sweat-based drug screening in action, we knew it would be a great fit for P&O Ferries and our need for a flexible system that we could use on board our ferries,” explained Grant Laversuch, Head of Safety & Designated Person Ashore at P&O Ferries. “This has proved to be the case, with the portable and non-invasive Intelligent Fingerprinting system giving us the ability to test on our ferries as needed. Having rolled out the innovative fingerprint solution to our ferries, we’re now looking at training additional HR team members so that we can extend the program to our employees onshore.”
P&O Ferries will deploy the Intelligent Fingerprinting Drug Screening System at its three UK ferry port sites at Larne in Northern Ireland, as well as Hull and Dover in England. The Company’s portable DSR-Plus readers and screening cartridges will be used to randomly test seafaring staff on board ferries in line with the company’s drug and alcohol policy.
“The ease-of-use and portability of our Intelligent Fingerprinting Drug Screening System makes it a powerful solution for random workplace testing across different locations. P&O Ferries’ deployment of fingerprint testing on its ferries demonstrates the system’s flexibility. It’s great that we’re not only helping the company maintain a safe and efficient work environment, but also equipping it with a more cost-effective method of testing,” added Harry Simeonidis, President and Chief Executive Officer at Intelligent Bio Solutions.
An introductory video demonstrating fingerprint-based drug testing in action is available here.
Recent INBS News
- Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach • GlobeNewswire Inc. • 10/31/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/29/2024 08:15:22 PM
- Intelligent Bio Solutions Announces Preliminary Unaudited Fiscal 2025 First Quarter Revenue Results • GlobeNewswire Inc. • 10/29/2024 12:30:00 PM
- Intelligent Bio Solutions Celebrates One Year Anniversary of Enhanced Workplace Safety with London-Based Real-Estate Developer, Mount Anvil • GlobeNewswire Inc. • 10/24/2024 12:30:00 PM
- Intelligent Bio Solutions Announces Adoption of its Non-Invasive Drug Screening Solution by Global Engineering Leader, Pyrotek • GlobeNewswire Inc. • 10/14/2024 12:00:00 PM
- Intelligent Bio Solutions Partners with Spirit Group as Australian Distributor, Expanding Community Impact with Intelligent Fingerprinting Drug Testing Solution • GlobeNewswire Inc. • 10/09/2024 12:30:00 PM
- GPS Marine Adopts Intelligent Bio Solutions’ Fingerprint Drug Testing Technology to Boost Workplace Safety in Maritime Services • GlobeNewswire Inc. • 10/01/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2024 09:15:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/27/2024 09:00:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2024 09:00:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/27/2024 09:00:15 PM
- Intelligent Bio Solutions Concludes In-Clinic Testing for Clinical Study Plan, Advancing Toward FDA 510(k) Submission • GlobeNewswire Inc. • 09/27/2024 12:30:00 PM
- UK’s Largest Greenhouse Complex, Thanet Earth, Adopts Intelligent Bio Solutions’ Fingerprint Drug Test to Enhance Workplace Safety • GlobeNewswire Inc. • 09/25/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2024 08:15:23 PM
- Intelligent Bio Solutions Inc. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results and Operational Highlights • GlobeNewswire Inc. • 09/19/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2024 08:52:01 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/18/2024 08:19:32 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/18/2024 01:18:33 PM
- Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Virtual Conference on September 18-19, 2024 • GlobeNewswire Inc. • 09/11/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 09:15:11 PM
- Intelligent Bio Solutions Inc. Announces Preliminary Full Fiscal Year 2024 Revenue Growth of 148% Year-Over-Year • GlobeNewswire Inc. • 09/09/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 09:15:12 PM
- Intelligent Bio Solutions Inc. Announces Progress Toward Completion of Clinical Study Plan Required for FDA 510(k) Submission • GlobeNewswire Inc. • 09/05/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 09:15:11 PM
- Intelligent Bio Solutions Inc. Reports 118% Year-Over-Year Growth in Customer Employee Base, Reaching an Estimated Total of 1.4 Million Employees • GlobeNewswire Inc. • 09/03/2024 12:30:00 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM